SEC v. Morrie Tobin; Milan Patel; Matthew Ledvina; Daniel Lacher; Roger Knox; and Wintercap SA, No. LR-24361, District of Massachusetts (Nov. 28, 2018) — Press Release
raw: Morrie Tobin et al.
Morrie Tobin et al., No. 1:18-CV-12451 (Nov. 28, 2018)
Morrie Tobin, Milan Patel, Matthew Ledvina, and Daniel Lacher were charged by the SEC for orchestrating a $165 million microcap stock manipulation scheme involving Environmental Packaging Technologies and CURE Pharmaceutical, using offshore entities and Swiss accounts to conceal Tobin's control and facilitate illegal sales.
The SEC charged four individuals for their roles in a scheme to profit from the manipulation and illegal sale of stock of two publicly traded companies. The defendants allegedly used offshore entities and a Swiss-based company, Wintercap SA, to hide Tobin's ownership and facilitate over $165 million in illegal stock sales. The SEC alleges the group paid promoters to artificially inflate Environmental Packaging's stock price, which more than doubled during the promotional campaign.
The Securities and Exchange Commission (SEC) has charged four individuals—Morrie Tobin, Milan Patel, Matthew Ledvina, and Daniel Lacher—for orchestrating a $165 million microcap stock manipulation scheme involving Environmental Packaging Technologies Holdings, Inc. and CURE Pharmaceutical Holding Corp. The defendants allegedly used offshore entities and a Swiss-based company, Wintercap SA, to hide Tobin's ownership and facilitate over $165 million in illegal stock sales. Patel and Ledvina, international tax attorneys, and Lacher, a Swiss resident, allegedly helped hide ownership and facilitated fraudulent sales through Wintercap SA, a Swiss firm run by Roger Knox. The group paid promoters to artificially inflate Environmental Packaging's stock price, which more than doubled, from approximately $1.05 per share to $2.21 per share, during the promotional campaign. The defendants obstructed the SEC's 2017 investigation by altering account records to conceal their roles. The SEC filed charges for violations of antifraud and registration provisions under the Securities Act and Exchange Act, seeking permanent injunctions, disgorgement, penalties, and penny stock bars.
Exhibits & Attached Documents (2)
Extracted insights
- $165.00M $165 million $100M–$1B
- person civil action
- company cure pharmaceutical holding corp.
- company environmental packaging technologies holdings, inc.
- organization Environmental Packaging Technologies Holdings, Inc.
- person fraudulent conduct
- person morrie tobin
- agency Securities and Exchange Commission
- organization Securities and Exchange Commission
- person stock price
- Securities and Exchange Commission charged four individuals for their roles in a scheme to profit from the manipulation and illegal sale of stock of Environmental Packaging Technologies Holdings, Inc. and CURE Pharmaceutical Holding Corp.
- Securities and Exchange Commission charged four individuals for their roles in a scheme to profit from the manipulation and illegal sale of stock of Environmental Packaging Technologies Holdings, Inc. and CURE Pharmaceutical Holding Corp.
- Morrie Tobin charged fraudulent microcap manipulation scheme
- Morrie Tobin orchestrated scheme through international accounts
- SEC charged four individuals
- SEC filed lawsuit against Morrie Tobin et al.
- Environmental Packaging Technologies Holdings, Inc. manipulated stock price
- CURE Pharmaceutical Holding Corp. manipulated stock price
- Morrie Tobin profited from illegal sale of stock
- SEC initiated civil action
- SEC alleged fraudulent conduct
- SEC charged four individuals
- four individuals profit from manipulation and illegal sale of stock of two publicly traded companies
- SEC filed Civil Action No. 1:18-CV-12451 (D. Mass.)
- Securities and Exchange Commission charged four individuals
- Four individuals participated in fraudulent microcap manipulation scheme
- Scheme involved manipulation and illegal sale of stock of Environmental Packaging Technologies Holdings, Inc. and CURE Pharmaceutical Holding Corp.
- Litigation Release No. 24361 dated November 28, 2018
- Civil Action No. 1:18-CV-12451 filed November 27, 2018
- SEC released Litigation Release No. 24361
SEC Charges Four in Fraudulent Microcap Manipulation Scheme Orchestrated Through International Accounts Litigation Release No. 24361 / November 28, 2018 Securities and Exchange Commission v. Morrie Tobin et al., Civil Action No. 1:18-CV-12451 (D. Mass. filed November 27, 2018) The Securities and Exchange Commission charged four individuals for their roles in a scheme to profit from the manipulation and illegal sale of stock of two publicly traded companies, Environmental Packaging Technologies Holdings, Inc. and CURE Pharmaceutical Holding Corp. According to the SEC's complaint, Morrie Tobin, a California resident, worked with co-defendants Milan Patel, Matthew Ledvina, and Daniel Lacher to facilitate Tobin's scheme. Patel and Ledvina, attorneys at an international tax law firm, and Lacher, a resident of Switzerland, allegedly hid Tobin's ownership and control over the companies by using offshore entitites to hold his stock and by establishing accounts to sell that stock at Wintercap SA, a Swiss-based company run by U.K. citizen Roger Knox. On October 2, 2018, the SEC filed an emergency action and obtained an asset freeze against Knox and Wintercap, charging them with a scheme that generated more than $165 million of illegal sales of stock in at least 50 microcap companies. The SEC's complaint charges that to maximize profits from the alleged scheme, the defendants arranged to pay a stock promoter to tout the stock of Environmental Packaging while creating the impression that the recommendation came from a neutral third party. Environmental Packaging shares more than doubled, from approximately $1.05 per share to $2.21 per share, during the promotional campaign. Patel, Ledvina, and Lacher allegedly planned to collect a percentage of the proceeds from the unlawful sales. According to the complaint, after the SEC halted trading in the securities of Environmental Packaging on June 27, 2017, the defendants took steps to obstruct the SEC's investigation - and conceal their own involvement in the matter - by arranging to change the names listed on Wintercap account records. The SEC's complaint, filed in the U.S. District Court in the District of Massachusetts, charges Tobin, Patel, Ledvina, and Lacher with violating various federal securities laws, including the antifraud provisions of Sections 17(a)(1) and (3) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5(a) and (c) thereunder, and the securities registration provisions of Sections 5(a) and (c) of the Securities Act. The SEC seeks a permanent injunction against future violations, disgorgement of allegedly ill-gotten gains plus prejudgment interest, penny stock bars, and monetary penalties. The SEC's case is being handled by J. Lauchlan Wash, Trevor Donelan, Eric Forni, David Scheffler, Rebecca Israel, Jonathan Allen, Kathleen Shields, and Amy Gwiazda of the SEC's Boston Regional Office, in coordination with the Enforcement Division's Microcap Fraud Task Force. The SEC appreciates the assistance of the FBI and the U.S. Attorney's Office for the District of Massachusetts, the Financial Industry Regulatory Authority (FINRA), the British Columbia Securities Commission, the Ontario Securities Commission, and the Malta Financial Services Authority. SEC Complaint
SEC Charges Four in Fraudulent Microcap Manipulation Scheme Orchestrated Through International Accounts Litigation Release No. 24361 / November 28, 2018 Securities and Exchange Commission v. Morrie Tobin et al., Civil Action No. 1:18-CV-12451 (D. Mass. filed November 27, 2018) The Securities and Exchange Commission charged four individuals for their roles in a scheme to profit from the manipulation and illegal sale of stock of two publicly traded companies, Environmental Packaging Technologies Holdings, Inc. and CURE Pharmaceutical Holding Corp. According to the SEC's complaint, Morrie Tobin, a California resident, worked with co-defendants Milan Patel, Matthew Ledvina, and Daniel Lacher to facilitate Tobin's scheme. Patel and Ledvina, attorneys at an international tax law firm, and Lacher, a resident of Switzerland, allegedly hid Tobin's ownership and control over the companies by using offshore entitites to hold his stock and by establishing accounts to sell that stock at Wintercap SA, a Swiss-based company run by U.K. citizen Roger Knox. On October 2, 2018, the SEC filed an emergency action and obtained an asset freeze against Knox and Wintercap, charging them with a scheme that generated more than $165 million of illegal sales of stock in at least 50 microcap companies. The SEC's complaint charges that to maximize profits from the alleged scheme, the defendants arranged to pay a stock promoter to tout the stock of Environmental Packaging while creating the impression that the recommendation came from a neutral third party. Environmental Packaging shares more than doubled, from approximately $1.05 per share to $2.21 per share, during the promotional campaign. Patel, Ledvina, and Lacher allegedly planned to collect a percentage of the proceeds from the unlawful sales. According to the complaint, after the SEC halted trading in the securities of Environmental Packaging on June 27, 2017, the defendants took steps to obstruct the SEC's investigation - and conceal their own involvement in the matter - by arranging to change the names listed on Wintercap account records. The SEC's complaint, filed in the U.S. District Court in the District of Massachusetts, charges Tobin, Patel, Ledvina, and Lacher with violating various federal securities laws, including the antifraud provisions of Sections 17(a)(1) and (3) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5(a) and (c) thereunder, and the securities registration provisions of Sections 5(a) and (c) of the Securities Act. The SEC seeks a permanent injunction against future violations, disgorgement of allegedly ill-gotten gains plus prejudgment interest, penny stock bars, and monetary penalties. The SEC's case is being handled by J. Lauchlan Wash, Trevor Donelan, Eric Forni, David Scheffler, Rebecca Israel, Jonathan Allen, Kathleen Shields, and Amy Gwiazda of the SEC's Boston Regional Office, in coordination with the Enforcement Division's Microcap Fraud Task Force. The SEC appreciates the assistance of the FBI and the U.S. Attorney's Office for the District of Massachusetts, the Financial Industry Regulatory Authority (FINRA), the British Columbia Securities Commission, the Ontario Securities Commission, and the Malta Financial Services Authority. SEC Complaint